MedPath

Computerized Cognitive Training in Epilepsy

Not Applicable
Withdrawn
Conditions
Epilepsy
Interventions
Behavioral: Monster Garden Exercise
Behavioral: Spatial Match Exercise
Behavioral: Temporal Sequence Reconstruction Exercise
Behavioral: Memory Match Exercise
Behavioral: Token Task Exercise
Behavioral: Memory Matrix Exercise
Behavioral: Familiar Faces Exercises
Behavioral: Story Recall Exercise
Behavioral: Lost in Migration Exercise
Behavioral: Sample-Match (Within Modality) Exercise
Behavioral: Pair-Match (Across-Modality) Exercise
Behavioral: Playing Koi Exercise
Behavioral: Triad-FiguresExercise
Registration Number
NCT02726191
Lead Sponsor
NYU Langone Health
Brief Summary

The purpose of this randomized uncontrolled single-site trial is to evaluate the efficacy of two novel computerized cognitive enhancing software packages for improving cognitive and behavioral outcomes in patients with epilepsy.

Detailed Description

The proposed investigation will be the first to pit two software packages against each other to evaluate the relative efficacy and feasibility of their use among patients with epilepsy. Pharmacotherapy fails to control seizures in approximately 30% of patients. Use of non-pharmacologic interventions, such as cognitive rehabilitation, has shown some benefit for improving cognitive functions and reducing mood symptoms. Each of the computer exercises employ a set of stimuli that are generalizable and mimic real-world experiences.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Documented diagnosis of epilepsy based on medical records. The records will be reviewed by the PI and the approved study personnel to confirm that a diagnosis of epilepsy has been made.
  • Must own a computer or have access to the internet.
Read More
Exclusion Criteria
  • Full Scale IQ < 80, as assessed by the WASI-II.
  • History of chronic progressive neurologic or neurodegenerative illnesses (e.g., Parkinson's disease, multiple sclerosis, dementia, primary or metastatic malignancy). Patients with headache or migraine are not excluded.
  • History of Axis I psychiatric illness with psychotic features. (e.g., schizophrenia). Patients with depression or anxiety (treated or untreated) without psychotic features are not excluded.
  • Visual or auditory impairment, which precludes participation in part, or all of the testing.
  • English as a first language will not be required, but participants must have either received some of their schooling in English or used English in their work for >10 years.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LumosityMonster Garden Exercise-
Posit ScienceTriad-FiguresExercise-
LumosityLost in Migration Exercise-
Posit ScienceToken Task Exercise-
Posit ScienceTemporal Sequence Reconstruction Exercise-
Posit ScienceSample-Match (Within Modality) Exercise-
LumosityFamiliar Faces Exercises-
Posit ScienceStory Recall Exercise-
Posit SciencePair-Match (Across-Modality) Exercise-
LumosityMemory Matrix Exercise-
Posit ScienceSpatial Match Exercise-
LumosityMemory Match Exercise-
LumosityPlaying Koi Exercise-
Primary Outcome Measures
NameTimeMethod
Total Index Score from the Repeatable Battery for the Assessment of Neurocognitive Status (RBANS)8 Weeks
Secondary Outcome Measures
NameTimeMethod
Perceived cognitive abilities on an index of subjective cognitive abilities (Cognitive Self-Report Questionnaire; CSRQ-25)8 Weeks
The Everyday Cognition Scale (ECog)8 Weeks
Measure of mood (Geriatric Depression Scale)8 Weeks

Trial Locations

Locations (1)

New York University School of Medicine

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath